Get started
GoodRx Holdings, Inc.GoodRx Holdings, Inc.GoodRx Holdings, Inc.

GoodRx Holdings, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

GDRX chart


Full chart

GDRX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.76 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.04 USD
Net income (FY)
‪−8.87 M‬ USD
Revenue (FY)
‪750.26 M‬ USD
Shares float
‪86.74 M‬
Beta (1Y)
0.78

Employees


Employees (FY)
694
Change (1Y)
−260 −27.25%
Revenue / Employee (1Y)
‪1.08 M‬ USD
Net income / Employee (1Y)
‪−12.78 K‬ USD

About GoodRx Holdings, Inc.


Sector
Technology Services
Industry
Internet Software/Services
CEO
Scott W. Wagner
Website
goodrx.com
Headquarters
Santa Monica
Founded
2011
FIGI
BBG00X0VP8D9
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2011 and is headquartered in Santa Monica, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GDRX news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GDRX is 4.58 USD — it has decreased by −1.62% in the past 24 hours. Watch GoodRx Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GoodRx Holdings, Inc. stocks are traded under the ticker GDRX.
GDRX stock has risen by 3.77% compared to the previous week, the month change is a −7.62% fall, over the last year GoodRx Holdings, Inc. has showed a −30.47% decrease.
We've gathered analysts' opinions on GoodRx Holdings, Inc. future price: according to them, GDRX price has a max estimate of 10.00 USD and a min estimate of 4.50 USD. Watch GDRX chart and read a more detailed GoodRx Holdings, Inc. stock forecast: see what analysts think of GoodRx Holdings, Inc. and suggest that you do with its stocks.
GDRX reached its all-time high on Sep 29, 2020 with the price of 64.22 USD, and its all-time low was 3.82 USD and was reached on Nov 9, 2022. View more price dynamics on GDRX chart.
See other stocks reaching their highest and lowest prices.
GDRX stock is 4.36% volatile and has beta coefficient of 0.78. Track GoodRx Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is GoodRx Holdings, Inc. there?
Today GoodRx Holdings, Inc. has the market capitalization of ‪1.76 B‬, it has increased by 2.75% over the last week.
Yes, you can track GoodRx Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
GoodRx Holdings, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
GDRX earnings for the last quarter are 0.08 USD per share, whereas the estimation was 0.09 USD resulting in a −7.99% surprise. The estimated earnings for the next quarter are 0.10 USD per share. See more details about GoodRx Holdings, Inc. earnings.
GoodRx Holdings, Inc. revenue for the last quarter amounts to ‪195.25 M‬ USD, despite the estimated figure of ‪195.66 M‬ USD. In the next quarter, revenue is expected to reach ‪199.76 M‬ USD.
GDRX net income for the last quarter is ‪3.96 M‬ USD, while the quarter before that showed ‪6.69 M‬ USD of net income which accounts for −40.77% change. Track more GoodRx Holdings, Inc. financial stats to get the full picture.
No, GDRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 694.00 employees. See our rating of the largest employees — is GoodRx Holdings, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GoodRx Holdings, Inc. EBITDA is ‪141.20 M‬ USD, and current EBITDA margin is 21.75%. See more stats in GoodRx Holdings, Inc. financial statements.
Like other stocks, GDRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GoodRx Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GoodRx Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GoodRx Holdings, Inc. stock shows the sell signal. See more of GoodRx Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.